Comparison between phytoestrogens and estradiol in the preventionof atheroma in ovariectomized cholesterol-fed rabbits

Climacteric

Volumn 9, Issue 6, 2006, Pages 430-436

  Haines, C ^a   James, A ^a   Sahota, D ^a   Chen, Z Y ^a   Panesar, N ^a   Tomlinson, B ^a   Chow, L ^a   Benzie, I ^b   Husband, A ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Atherosclerosis; Estradiol; Phytoestrogen

Indexed keywords

CHOLESTEROL; ESTRADIOL; ISOFLAVONE; PHYTOESTROGEN; RED CLOVER EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROMA; CHOLESTEROL DIET; CONTROL GROUP; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HYPERCHOLESTEROLEMIA; MEASUREMENT; MENOPAUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RABBIT; RED CLOVER; STAINING; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; AORTA; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, DIETARY; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; OVARIECTOMY; PHYTOESTROGENS; RABBITS; RANDOM ALLOCATION;

EID: 33750634145     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130600863266     Document Type: Article

References (25)

1. The World Health Report 1997. Geneva: World Health Organization
2. Becker RC. Cardiovascular disease in women: facts and statistics. Cardiology 1995;86:264
3. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Ann Rev Public Health 1998;19:55-72
4. Seed M, Knopp RH. Estrogens, lipoproteins, and cardiovascular risk factors: an update following the randomized placebo-controlled trials of hormone-replacement therapy. Current Opinion Lipidol 2004;15:459-67
5. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-13
6. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33
7. Grodstein F, Manson JE, Stampfer MJ. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health 2006;15:35-44
8. Kaufert P, Boggs PP, Ettinger B, et al. Women and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society 1997 Menopause Survey. Menopause 1998;5:197-202
9. Fowler ME. Plant poisoning in free living wild animals: a review. J Wildlife Dis 1983;19:34-43
10. Murkies AL, Wilcox G, Davis SR. Phytoestrogens exhibit either agonistic or antagonistic properties in humans depending upon the tissue estrogen receptor. J Clin Endocrinol Metab 1998;83:297-303
11. Price KR, Fenwick GR. Naturally occurring estrogens in foods: a review. Food Addit Contam 1985;2:73-106
12. Adlercreutz H, Mazur W. Phyto-estrogens and western diseases. Ann Med 1995;29:95-120
13. Haines CJ, James AE, Panesar NS, et al. The effect of percutaneous oestradiol on atheroma formation in ovariectomized cholesterol-fed rabbits. Atherosclerosis 1999;143:369-75
14. Rao VB, Rao HV. Neural Networks and Fuzzy Logic, 1st edn. New York: MIS Press, 1995:271-305
15. Wilson RB, Miller RA, Middleton CC, et al. Atherosclerosis in rabbits fed a low cholesterol diet for 5 years. Atherosclerosis 1982;2:228-41
16. Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP Assay. Ann Biochem 1996;239:70-6
17. Bjarnason NH, Haarbo J, Byrjalsen I, et al. Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol fed rabbits. Circulation 1997;96:1964-9
18. Yamakoshi J, Piskula MK, Izumi T, et al. Isoflavone: a glycone-rich extract without soy protein attenuates atherosclerosis development in cholesterol-fed rabbits. J Nutr 2000;130:1887-93
19. Nestel PJ, Pomeroy S, Kay S, et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 1999;84:895-8
20. Anthony MS, Clarkson TB, Bullock BC, et al. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol 1997;17:2524-31
21. Clarkson TB, Anthony MS, Morgan TM. Inhibition of postmenopausal atherosclerosis progression: a comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 2001;86:41-7
22. Alexandersen P, Haarbo J, Breinholt V, et al. Dietary phytoestrogens and estrogen inhibit experimental atherosclerosis. Climacteric 2001;4:151-9
23. Mortensen A, Breinholt V, Dalsgaard T, et al. 17β-Estradiol but not the phytoestrogen naringenin attenuates aortic cholesterol accumulation in WHHL rabbits. J Lipid Res 2001;42:834-43
24. Serafini M, Del Rio D, Crozier A, et al. Effect of changes in fruit and vegetable intake on plasma antioxidant defenses in humans. Am J Clin Nutrition 2005;81:531-2
25. Anderson GL, Hutchinson F, Limacher M, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-12